Soumoy, L.; Genbauffe, A.; Sant’Angelo, D.; Everaert, M.; Mukeba-Harchies, L.; Sarry, J.-E.; Declèves, A.-E.; Journe, F.
Therapeutic Potential of Glutaminase Inhibition Targeting Metabolic Adaptations in Resistant Melanomas to Targeted Therapy. Int. J. Mol. Sci. 2025, 26, 8241.
https://doi.org/10.3390/ijms26178241
AMA Style
Soumoy L, Genbauffe A, Sant’Angelo D, Everaert M, Mukeba-Harchies L, Sarry J-E, Declèves A-E, Journe F.
Therapeutic Potential of Glutaminase Inhibition Targeting Metabolic Adaptations in Resistant Melanomas to Targeted Therapy. International Journal of Molecular Sciences. 2025; 26(17):8241.
https://doi.org/10.3390/ijms26178241
Chicago/Turabian Style
Soumoy, Laura, Aline Genbauffe, Dorianne Sant’Angelo, Maude Everaert, Léa Mukeba-Harchies, Jean-Emmanuel Sarry, Anne-Emilie Declèves, and Fabrice Journe.
2025. "Therapeutic Potential of Glutaminase Inhibition Targeting Metabolic Adaptations in Resistant Melanomas to Targeted Therapy" International Journal of Molecular Sciences 26, no. 17: 8241.
https://doi.org/10.3390/ijms26178241
APA Style
Soumoy, L., Genbauffe, A., Sant’Angelo, D., Everaert, M., Mukeba-Harchies, L., Sarry, J.-E., Declèves, A.-E., & Journe, F.
(2025). Therapeutic Potential of Glutaminase Inhibition Targeting Metabolic Adaptations in Resistant Melanomas to Targeted Therapy. International Journal of Molecular Sciences, 26(17), 8241.
https://doi.org/10.3390/ijms26178241